questionsmedicales.fr
Glucides
Hétérosides
Glucosides cardiotoniques
Glucosides digitaliques
Lanatoside
Lanatoside : Questions médicales fréquentes
Diagnostic
5
Intoxication
Lanatosides
Tests de laboratoire
Électrocardiogramme
Lanatosides
Dosage sanguin
Palpitations
Nausées
Troubles de la vision
Efficacité thérapeutique
Symptômes cardiaques
Électrocardiogramme
Bradycardie
Arythmies
Troubles gastro-intestinaux
Symptômes
5
Surdose
Nausées
Arythmies cardiaques
Réaction allergique
Éruption cutanée
Démangeaisons
Effets secondaires
Fatigue
Troubles digestifs
Troubles de la vision
Vision floue
Halos
Palpitations
Bradycardie
Arythmies
Prévention
5
Intoxication
Suivi médical
Posologie
Conseils aux patients
Effets secondaires
Avis médical
Aliments
Pamplemousse
Efficacité
Éducation des patients
Effets
Intoxication
Précautions
Suivi régulier
Interactions médicamenteuses
Traitements
5
Administration orale
Intraveineuse
Lanatosides
Interactions médicamenteuses
Diurétiques
Antibiotiques
Posologie
Effets indésirables
Lanatosides
Insuffisance cardiaque
Congestive
Lanatosides
Surveillance
Niveaux sanguins
Électrocardiogramme
Complications
5
Complications
Arythmies
Troubles électrolytiques
Arythmie
Antidotes
Gestion
Troubles rénaux
Utilisation prolongée
Surveillance
Surdose
Arythmies graves
Mort
Prévention
Suivi médical
Signes d'alerte
Facteurs de risque
5
Facteurs de risque
Insuffisance rénale
Médicaments cardiaques
Antécédents médicaux
Arythmies
Insuffisance cardiaque
Âge
Sensibilité
Surveillance accrue
Médicaments
Diurétiques
Antibiotiques
Maladies cardiaques
Facteurs de risque
Effets indésirables
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lanatoside : Questions médicales les plus fréquentes",
"headline": "Lanatoside : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lanatoside : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-17",
"dateModified": "2026-04-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lanatoside"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Glucosides digitaliques",
"url": "https://questionsmedicales.fr/mesh/D004071",
"about": {
"@type": "MedicalCondition",
"name": "Glucosides digitaliques",
"code": {
"@type": "MedicalCode",
"code": "D004071",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.408.180.261"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Deslanoside",
"alternateName": "Deslanoside",
"url": "https://questionsmedicales.fr/mesh/D003892",
"about": {
"@type": "MedicalCondition",
"name": "Deslanoside",
"code": {
"@type": "MedicalCode",
"code": "D003892",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D09.408.180.261.657.200"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Lanatoside",
"alternateName": "Lanatosides",
"code": {
"@type": "MedicalCode",
"code": "D007799",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Yaozong Xia",
"url": "https://questionsmedicales.fr/author/Yaozong%20Xia",
"affiliation": {
"@type": "Organization",
"name": "School of Clinical Medicine, Chengdu Medical College, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Teng Liu",
"url": "https://questionsmedicales.fr/author/Teng%20Liu",
"affiliation": {
"@type": "Organization",
"name": "School of Clinical Medicine, Chengdu Medical College, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Shihua Deng",
"url": "https://questionsmedicales.fr/author/Shihua%20Deng",
"affiliation": {
"@type": "Organization",
"name": "Department of Laboratory Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Li Li",
"url": "https://questionsmedicales.fr/author/Li%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Clinical Medicine, Chengdu Medical College, Chengdu, China."
}
},
{
"@type": "Person",
"name": "Jin Li",
"url": "https://questionsmedicales.fr/author/Jin%20Li",
"affiliation": {
"@type": "Organization",
"name": "School of Clinical Medicine, Chengdu Medical College, Chengdu, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Suppression of ER-stress induction of GRP78 as an anti-neoplastic mechanism of the cardiac glycoside Lanatoside C in pancreatic cancer: Lanatoside C suppresses GRP78 stress induction.",
"datePublished": "2021-11-09",
"url": "https://questionsmedicales.fr/article/34768108",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.neo.2021.10.004"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lanatoside C induces ferroptosis in non-small cell lung cancer",
"datePublished": "2024-05-28",
"url": "https://questionsmedicales.fr/article/38881941",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.21037/tcr-23-2285"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lanatoside C inhibits herpes simplex virus 1 replication by regulating NRF2 distribution within cells.",
"datePublished": "2023-12-25",
"url": "https://questionsmedicales.fr/article/38185069",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.phymed.2023.155308"
}
},
{
"@type": "ScholarlyArticle",
"name": "Lanatoside C Induces G2/M Cell Cycle Arrest and Suppresses Cancer Cell Growth by Attenuating MAPK, Wnt, JAK-STAT, and PI3K/AKT/mTOR Signaling Pathways.",
"datePublished": "2019-11-27",
"url": "https://questionsmedicales.fr/article/31783627",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/biom9120792"
}
},
{
"@type": "ScholarlyArticle",
"name": "Cardiac glycosides target barrier inflammation of the vasculature, meninges and choroid plexus.",
"datePublished": "2021-02-26",
"url": "https://questionsmedicales.fr/article/33637884",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s42003-021-01787-x"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Glucides",
"item": "https://questionsmedicales.fr/mesh/D002241"
},
{
"@type": "ListItem",
"position": 3,
"name": "Hétérosides",
"item": "https://questionsmedicales.fr/mesh/D006027"
},
{
"@type": "ListItem",
"position": 4,
"name": "Glucosides cardiotoniques",
"item": "https://questionsmedicales.fr/mesh/D002301"
},
{
"@type": "ListItem",
"position": 5,
"name": "Glucosides digitaliques",
"item": "https://questionsmedicales.fr/mesh/D004071"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lanatoside",
"item": "https://questionsmedicales.fr/mesh/D007799"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lanatoside - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lanatoside",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-02",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lanatoside",
"description": "Comment diagnostiquer une intoxication aux lanatosides ?\nQuels tests sont utilisés pour évaluer l'effet des lanatosides ?\nQuels symptômes indiquent un besoin de diagnostic ?\nComment évaluer l'efficacité des lanatosides ?\nQuels signes cliniques sont associés aux lanatosides ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lanatoside",
"description": "Quels sont les symptômes d'une surdose de lanatosides ?\nComment reconnaître une réaction allergique aux lanatosides ?\nQuels effets secondaires sont courants avec les lanatosides ?\nLes lanatosides provoquent-ils des troubles de la vision ?\nQuels symptômes cardiaques sont liés aux lanatosides ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lanatoside",
"description": "Comment prévenir une intoxication aux lanatosides ?\nQuels conseils donner aux patients sous lanatosides ?\nLes patients doivent-ils éviter certains aliments ?\nComment éduquer les patients sur les lanatosides ?\nQuelles précautions prendre lors de l'utilisation des lanatosides ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lanatoside",
"description": "Comment les lanatosides sont-ils administrés ?\nQuels médicaments interagissent avec les lanatosides ?\nQuelle est la posologie standard des lanatosides ?\nLes lanatosides sont-ils utilisés en cas d'insuffisance cardiaque ?\nComment surveiller un patient sous lanatosides ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lanatoside",
"description": "Quelles complications peuvent survenir avec les lanatosides ?\nComment gérer une arythmie causée par les lanatosides ?\nLes lanatosides peuvent-ils causer des troubles rénaux ?\nQuels sont les risques d'une surdose de lanatosides ?\nComment prévenir les complications liées aux lanatosides ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lanatoside",
"description": "Quels facteurs augmentent le risque d'intoxication aux lanatosides ?\nLes antécédents médicaux influencent-ils l'utilisation des lanatosides ?\nComment l'âge affecte-t-il le traitement par lanatosides ?\nQuels médicaments augmentent le risque d'effets indésirables ?\nLes maladies cardiaques préexistantes sont-elles un facteur de risque ?",
"url": "https://questionsmedicales.fr/mesh/D007799#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux lanatosides ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un diagnostic repose sur les symptômes cliniques et des tests sanguins pour mesurer les niveaux de lanatosides."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer l'effet des lanatosides ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests incluent l'électrocardiogramme (ECG) et les dosages sanguins des lanatosides."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin de diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des palpitations, des nausées ou des troubles de la vision peuvent indiquer un problème."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'efficacité des lanatosides ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par l'amélioration des symptômes cardiaques et des résultats ECG."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques sont associés aux lanatosides ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les signes incluent bradycardie, arythmies et troubles gastro-intestinaux."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une surdose de lanatosides ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent nausées, vomissements, confusion et arythmies cardiaques."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique aux lanatosides ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent se manifester par des éruptions cutanées, démangeaisons ou œdème."
}
},
{
"@type": "Question",
"name": "Quels effets secondaires sont courants avec les lanatosides ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les effets secondaires incluent fatigue, troubles visuels et troubles digestifs."
}
},
{
"@type": "Question",
"name": "Les lanatosides provoquent-ils des troubles de la vision ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles visuels comme la vision floue ou les halos peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels symptômes cardiaques sont liés aux lanatosides ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent palpitations, bradycardie et arythmies."
}
},
{
"@type": "Question",
"name": "Comment prévenir une intoxication aux lanatosides ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un suivi médical régulier et le respect des posologies prescrites."
}
},
{
"@type": "Question",
"name": "Quels conseils donner aux patients sous lanatosides ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il est conseillé de signaler tout effet secondaire et de ne pas modifier la dose sans avis médical."
}
},
{
"@type": "Question",
"name": "Les patients doivent-ils éviter certains aliments ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains aliments comme le pamplemousse peuvent interférer avec l'efficacité des lanatosides."
}
},
{
"@type": "Question",
"name": "Comment éduquer les patients sur les lanatosides ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation doit inclure les effets, les doses et les signes d'intoxication potentiels."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre lors de l'utilisation des lanatosides ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les précautions incluent un suivi régulier et l'évaluation des interactions médicamenteuses."
}
},
{
"@type": "Question",
"name": "Comment les lanatosides sont-ils administrés ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement administrés par voie orale ou intraveineuse, selon la condition."
}
},
{
"@type": "Question",
"name": "Quels médicaments interagissent avec les lanatosides ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des médicaments comme les diurétiques et certains antibiotiques peuvent interagir."
}
},
{
"@type": "Question",
"name": "Quelle est la posologie standard des lanatosides ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "La posologie varie selon le patient, mais commence souvent à faible dose pour éviter les effets indésirables."
}
},
{
"@type": "Question",
"name": "Les lanatosides sont-ils utilisés en cas d'insuffisance cardiaque ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils sont souvent prescrits pour traiter l'insuffisance cardiaque congestive."
}
},
{
"@type": "Question",
"name": "Comment surveiller un patient sous lanatosides ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La surveillance inclut des contrôles réguliers des niveaux sanguins et des ECG."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec les lanatosides ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent arythmies, insuffisance cardiaque et troubles électrolytiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une arythmie causée par les lanatosides ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion inclut l'arrêt du médicament et l'administration d'antidotes si nécessaire."
}
},
{
"@type": "Question",
"name": "Les lanatosides peuvent-ils causer des troubles rénaux ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une utilisation prolongée peut entraîner des troubles rénaux, nécessitant une surveillance."
}
},
{
"@type": "Question",
"name": "Quels sont les risques d'une surdose de lanatosides ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les risques incluent des arythmies graves, des troubles de la conduction et la mort."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux lanatosides ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un suivi médical régulier et une éducation sur les signes d'alerte."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'intoxication aux lanatosides ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent l'insuffisance rénale, l'âge avancé et l'utilisation d'autres médicaments cardiaques."
}
},
{
"@type": "Question",
"name": "Les antécédents médicaux influencent-ils l'utilisation des lanatosides ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents d'arythmies ou d'insuffisance cardiaque augmentent le risque."
}
},
{
"@type": "Question",
"name": "Comment l'âge affecte-t-il le traitement par lanatosides ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées sont plus sensibles aux effets des lanatosides et nécessitent une surveillance accrue."
}
},
{
"@type": "Question",
"name": "Quels médicaments augmentent le risque d'effets indésirables ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diurétiques et certains antibiotiques peuvent augmenter le risque d'effets indésirables."
}
},
{
"@type": "Question",
"name": "Les maladies cardiaques préexistantes sont-elles un facteur de risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les maladies cardiaques préexistantes augmentent le risque d'effets indésirables avec les lanatosides."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 08/04/2026
Contenu vérifié selon les dernières recommandations médicales
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Department of Laboratory Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Laboratory Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Department of Laboratory Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
School of Clinical Medicine, Chengdu Medical College, Chengdu, China.
Department of Laboratory Medicine, the First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California, USA; USC Norris Comprehensive Cancer Center.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California, USA; USC Norris Comprehensive Cancer Center.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Biochemistry and Molecular Medicine, University of Southern California, Keck School of Medicine, Los Angeles, California, USA; USC Norris Comprehensive Cancer Center. Electronic address: amylee@usc.edu.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China; Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, National-Regional Key Technology Engineering Laboratory for Medical Ultrasound, School of Biomedical Engineering, Shenzhen University Medical School, Shenzhen 518060, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pharmacy, The First Affiliated Hospital of Naval Medical University, Shanghai 200433, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China.
Publications dans "Lanatoside" :
1 publication dans cette catégorie
Affiliations :
Department of Pain Medicine and Shenzhen Municipal Key Laboratory for Pain Medicine, National Key Clinic of Pain Medicine, Shenzhen Nanshan People's Hospital, and the 6th Affiliated Hospital of Shenzhen University Health Science Center, Shenzhen 518060, China. Electronic address: nsyyjoe@live.cn.
Publications dans "Lanatoside" :
The 78 kilodalton glucose-regulated protein (GRP78) is a major endoplasmic reticulum (ER) molecular chaperone with antiapoptotic properties and a key regulator of the unfolded protein response (UPR). ...
Non-small cell lung cancer (NSCLC) is a common malignant tumor worldwide, remaining resistant to chemotherapy drugs. Lanatoside C can inhibit the growth of cancer cell lines. In this study we aimed to...
Experiments...
The results showed that lanatoside C had an inhibitory effect on the growth of A549 cells, and the dose of lanatoside C used in this experiment was set at 0.4 µM for 24 hours. When A549 cells were tre...
Collectively, lanatoside C could inhibit the proliferation and induce ferroptosis, and have a biological effect on inducing ferroptosis in NSCLC....
In the past decades, extensive research has been conducted to identify new drug targets for the treatment of Herpes simplex virus type 1 (HSV-1) infections. However, the emergence of drug-resistant HS...
This study aimed to investigate the antiviral activity of LanC against HSV-1 and elucidate its molecular mechanisms....
The in vitro antiviral activity of LanC was assessed by examining the levels of viral genes, proteins, and virus titers in HSV-1-infected ARPE-19 and Vero cells. Immunofluorescence (IF) analysis was p...
Our findings demonstrate that LanC significantly inhibits HSV-1 replication both in vitro and in vivo. The antiviral effect of LanC is mediated by the perinuclear translocation of NRF2....
LanC exhibits anti-HSV-1 effects in viral infections, which are associated with the intracellular translocation of NRF2. These findings suggest that LanC has the potential to serve as a novel NRF2 mod...
Cardiac glycosides (CGs) are a diverse family of naturally derived compounds having a steroid and glycone moiety in their structures. CG molecules inhibit the α-subunit of ubiquitous transmembrane pro...
Neuroinflammation is a key component of virtually all neurodegenerative diseases, preceding neuronal loss and associating directly with cognitive impairment. Neuroinflammatory signals can originate an...
Cervical cancer is one of the leading causes of cancer-associated mortality in gynecological diseases and ranks third among female cancers worldwide. Although early detection and vaccination have redu...